13. Goodwill and Other Intangible Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquired goodwill |
|
Patents and technologies |
|
Marketing and distribution rights |
|
Production rights |
|
Software |
|
Other rights |
|
Advance payments |
|
Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
€ million |
|
€ million |
|
€ million |
|
€ million |
|
€ million |
|
€ million |
|
€ million |
|
€ million |
Cost of acquisition or generation, December 31, 2021 |
|
759 |
|
208 |
|
463 |
|
133 |
|
172 |
|
244 |
|
49 |
|
2,028 |
Acquisitions |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
Capital expenditures |
|
– |
|
– |
|
– |
|
– |
|
2 |
|
6 |
|
19 |
|
27 |
Retirements |
|
(3) |
|
– |
|
– |
|
– |
|
(6) |
|
(7) |
|
– |
|
(16) |
Transfers |
|
– |
|
– |
|
2 |
|
– |
|
13 |
|
(11) |
|
(10) |
|
(6) |
Transfers (IFRS 5) |
|
– |
|
(1) |
|
(4) |
|
– |
|
– |
|
(3) |
|
– |
|
(8) |
Exchange differences |
|
7 |
|
5 |
|
5 |
|
– |
|
– |
|
– |
|
– |
|
17 |
Cost of acquisition or generation, December 31, 2022 |
|
763 |
|
212 |
|
466 |
|
133 |
|
181 |
|
229 |
|
58 |
|
2,042 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated amortization, impairment losses and impairment loss reversals, December 31, 2022 |
|
34 |
|
47 |
|
149 |
|
132 |
|
163 |
|
185 |
|
– |
|
710 |
Carrying amounts, December 31, 2022 |
|
729 |
|
165 |
|
317 |
|
1 |
|
18 |
|
44 |
|
58 |
|
1,332 |
Amortization and impairment losses |
|
33 |
|
18 |
|
86 |
|
– |
|
9 |
|
10 |
|
– |
|
156 |
Amortization |
|
– |
|
18 |
|
40 |
|
– |
|
9 |
|
9 |
|
– |
|
76 |
Impairment losses |
|
33 |
|
– |
|
46 |
|
– |
|
– |
|
1 |
|
– |
|
80 |
Impairment loss reversals |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
In the reporting year, impairment losses of €80 million (previous year: €1 million) were recognized on goodwill and other intangible assets. These were primarily due to impairment testing in the reporting year 2022. The items of goodwill significant for the Covestro Group and a detailed description of the method for impairment testing goodwill and other intangible assets are presented in section “Impairment Testing” in note 3 “Accounting Policies and Valuation Principles.” As in the previous year, there were no impairment loss reversals.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquired goodwill |
|
Patents and technologies |
|
Marketing and distribution rights |
|
Production rights |
|
Software |
|
Other rights |
|
Advance payments |
|
Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
€ million |
|
€ million |
|
€ million |
|
€ million |
|
€ million |
|
€ million |
|
€ million |
|
€ million |
Cost of acquisition or generation, December 31, 2020 |
|
257 |
|
28 |
|
40 |
|
132 |
|
170 |
|
203 |
|
34 |
|
864 |
Acquisitions |
|
489 |
|
176 |
|
412 |
|
– |
|
– |
|
37 |
|
– |
|
1,114 |
Capital expenditures |
|
– |
|
– |
|
– |
|
– |
|
2 |
|
2 |
|
15 |
|
19 |
Retirements |
|
– |
|
– |
|
– |
|
– |
|
– |
|
(1) |
|
– |
|
(1) |
Transfers |
|
– |
|
– |
|
1 |
|
– |
|
1 |
|
– |
|
– |
|
2 |
Transfers (IFRS 5) |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
Exchange differences |
|
13 |
|
4 |
|
10 |
|
1 |
|
(1) |
|
3 |
|
– |
|
30 |
Cost of acquisition or generation, December 31, 2021 |
|
759 |
|
208 |
|
463 |
|
133 |
|
172 |
|
244 |
|
49 |
|
2,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated amortization, impairment losses and impairment loss reversals, December 31, 2021 |
|
2 |
|
27 |
|
64 |
|
132 |
|
157 |
|
183 |
|
– |
|
565 |
Carrying amounts, December 31, 2021 |
|
757 |
|
181 |
|
399 |
|
1 |
|
15 |
|
61 |
|
49 |
|
1,463 |
Amortization and impairment losses |
|
– |
|
13 |
|
30 |
|
2 |
|
8 |
|
10 |
|
– |
|
63 |
Amortization |
|
– |
|
13 |
|
30 |
|
1 |
|
8 |
|
10 |
|
– |
|
62 |
Impairment losses |
|
– |
|
– |
|
– |
|
1 |
|
– |
|
– |
|
– |
|
1 |
Impairment loss reversals |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
The acquisition of the Resins & Functional Materials (RFM) business from Koninklijke DSM N.V., Heerlen (Netherlands), resulted in significant additions to goodwill and other intangible assets in the previous year.